Zoetis to acquire Nexvet Veterinary Biologic Therapeutics Co.April 13, 2017Zoetis Inc. announced it will purchase Nexvet Biopharma veterinary biologic therapeutics company for US $6.72 per share, or a valuation of approximately US $85 million. Pending approval, the purchase is expected to be completed during the second half of 2017.
Education Center - SponsoredReclaiming Lost Hours: How Digital Prescription Management Is Reshaping Veterinary Workflowsby • MWI Animal HealthAs administrative burdens grow, digital prescription management offers veterinary teams a path to greater efficiency, fewer errors, and more time for patient care.
